PROCEPT BioRobotics® to Report Third Quarter 2025 Financial Results on November 4, 2025
PROCEPT BioRobotics (Nasdaq: PRCT) announced it will report third quarter 2025 financial results after market close on Tuesday, November 4, 2025.
Management will host a conference call the same day at 4:30 p.m. Eastern Time. Investors can listen via webcast or dial-in registration. Live and archived audio will be available in the company’s Investors section; each webcast will be replayable for at least 90 days.
PROCEPT BioRobotics (Nasdaq: PRCT) ha annunciato che riferirà i risultati finanziari del terzo trimestre 2025 dopo la chiusura del mercato martedì 4 novembre 2025.
La direzione terrà una conference call nello stesso giorno alle 16:30 ora orientale. Gli investitori potranno ascoltare tramite webcast o registrazione telefonica. L'audio dal vivo e quello archiviato sarà disponibile nella sezione Investitori dell'azienda; ogni webcast sarà riprodotto almeno per 90 giorni.
PROCEPT BioRobotics (Nasdaq: PRCT) anunció que reportará los resultados financieros del tercer trimestre de 2025 después del cierre del mercado el martes 4 de noviembre de 2025.
La dirección organizará una llamada de conferencia ese mismo día a las 16:30 hora del Este. Los inversores pueden escuchar mediante webcast o registro telefónico. El audio en vivo y el archivo estará disponible en la sección de Inversores de la empresa; cada webcast se podrá volver a reproducir durante al menos 90 días.
PROCEPT BioRobotics (나스닥: PRCT)는 2025년 3분기의 재무 실적을 2025년 11월 4일 화요일 장 마감 후에 발표한다고 발표했습니다.
경영진은 같은 날 동부 표준시 기준 오후 4시 30분에 컨퍼런스 콜을 주최합니다. 투자자는 웹캐스트를 통해 들을 수 있거나 전화 등록으로 참여할 수 있습니다. 생방송 및 아카이브 오디오는 회사의 투자자 섹션에서 이용 가능하며 각 웹캐스트는 최소 90일간 재생됩니다.
PROCEPT BioRobotics (Nasdaq : PRCT) a annoncé qu’il publiera les résultats financiers du troisième trimestre 2025 après la clôture du marché le mardi 4 novembre 2025.
La direction organisera une conférence téléphonique le même jour à 16 h 30, heure de l’Est. Les investisseurs pourront écouter via webcast ou par inscription téléphonique. L’audio en direct et les archives seront disponibles dans la section Investisseurs de l’entreprise; chaque webcast sera réécoutable pendant au moins 90 jours.
PROCEPT BioRobotics (Nasdaq: PRCT) gab bekannt, dass die Finanzergebnisse des dritten Quartals 2025 nach Börsenschluss am Dienstag, dem 4. November 2025 veröffentlicht werden.
Das Management wird am selben Tag um 16:30 Uhr Ostzeit eine Telefonkonferenz abhalten. Investoren können per Webcast zuhören oder sich telefonisch registrieren. Live- und Archiv-Audio wird im Bereich Investoren des Unternehmens verfügbar sein; jeder Webcast wird für mindestens 90 Tage erneut wiedergegeben.
PROCEPT BioRobotics (بورصة ناسداك: PRCT) أعلنت أنها ستعلن عن نتائجها المالية للربع الثالث من عام 2025 بعد إغلاق السوق يوم الثلاثاء 4 نوفمبر 2025.
ستنظم الإدارة مؤتمر اتصال في نفس اليوم في الساعة 4:30 مساءً بتوقيت شرق الولايات المتحدة. يمكن للمستثمرين الاستماع عبر البث المباشر أو التسجيل الهاتف. سيكون الصوت المباشر والارشيف متاحين في قسم المستثمرون بالشركة؛ سيكون بإمكان كل بث ويب معاودة الاستماع لمدة لا تقل عن 90 يوماً.
PROCEPT BioRobotics（纳斯达克：PRCT）宣布将公布2025年第三季度的财务业绩，将在2025年11月4日（星期二）股市收盘后发布。
管理层将于同日举行电话会议，时间为美东时间下午4:30。投资者可以通过 webcast 收听或注册电话参与。现场及存档音频将可在公司的投资者板块获取；每场 webcast 至少可回放90 天。
- None.
- None.
SAN JOSE, Calif., Oct. 15, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (the “Company”) (Nasdaq: PRCT), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today announced it will report financial results for the third quarter of 2025 after market close on Tuesday, November 4, 2025. The Company’s management will host a corresponding conference call beginning at 4:30 p.m. Eastern Time.
Investors interested in listening to the conference call may do so by following one of the below links:
- Webcast link for interested listeners:
- Dial-in registration for sell-side research analysts:
Live audio of the webcast will be available on the “Investors” section of the Company’s website at: https://ir.procept-biorobotics.com.
An archived recording will be available on the “Investors” section of the Company’s website at: https://ir.procept-biorobotics.com. Each webcast will be available for replay for at least 90 days after the event.
About PROCEPT BioRobotics Corporation
PROCEPT BioRobotics’ mission is to revolutionize BPH treatment globally in partnership with urologists by delivering best-in-class robotic solutions that positively impact patients and drive value. PROCEPT BioRobotics manufactures the AQUABEAM® and HYDROS™ Robotic Systems. The HYDROS Robotic System is the only AI-Powered, robotic technology that delivers Aquablation therapy. PROCEPT BioRobotics designed Aquablation therapy to deliver effective, safe, and durable outcomes for males suffering from lower urinary tract symptoms or LUTS, due to BPH that are independent of prostate size and shape or surgeon experience. BPH is the most common prostate disease and impacts approximately 40 million men in the United States. The Company has developed a significant and growing body of clinical evidence with over 150 peer-reviewed publications, supporting the benefits and clinical advantages of Aquablation therapy.
Investor Contact:
Matt Bacso
VP, Investor Relations and Business Operations
m.bacso@PROCEPT-BioRobotics.com
FAQ
When will PROCEPT BioRobotics (PRCT) report Q3 2025 results?
What time is the PROCEPT BioRobotics (PRCT) Q3 2025 conference call?
How can investors listen to PROCEPT BioRobotics (PRCT) Q3 2025 earnings webcast?
Will PROCEPT BioRobotics (PRCT) provide a replay of the Q3 2025 webcast?
Is there a separate dial-in for sell-side analysts for PROCEPT BioRobotics (PRCT)?
